Gara Jalqabaatti › Myelofibrosis › Utah › Salt Lake City
Qorannoo klinikaalii Myelofibrosis Salt Lake City, UT keessatti
Qorannoo 10 Myelofibrosis f Salt Lake City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1/2
- Huntsman Cancer Institute, Salt Lake City
Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Namoota walitti qabaa jiraSadarkaa 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute At University of Utah, Salt Lake City
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute, Salt Lake City
AlloHCT With PegINFa for Myelofibrosis
Namoota walitti qabaa jiraSadarkaa 1
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Namoota walitti qabaa jiraSadarkaa 1
- University of Utah, Salt Lake City
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Namoota walitti qabaa jiraSadarkaa 2
- Huntsman Cancer Institute, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Salt Lake City
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Namoota walitti qabaa jiraSadarkaa 3
- University of Utah, Huntsman Cancer Institute, Salt Lake City
Qorannoo Myelofibrosis magaalota biroo keessatti
- Houston, TXQorannoo 19
- New York City, NYQorannoo 18
- Boston, MAQorannoo 12
- Durham, NCQorannoo 12
- Columbus, OHQorannoo 11
- Seattle, WAQorannoo 11
- Miami, FLQorannoo 10
- Atlanta, GAQorannoo 9
- Baldwin Park, CAQorannoo 9
- Nashville, TNQorannoo 9
- Tampa, FLQorannoo 9
- Cleveland, OHQorannoo 9
Qorannoo biroo Salt Lake City keessatti
- Kansara Qara'a Non-Small CellQorannoo 31
- Saree (Gosoota Hunda)Qorannoo 27
- Saree OljooQorannoo 27
- Kansarii ColorectalQorannoo 22
- Dhibee QaraQorannoo 21
- MelanomaQorannoo 21
- Myeloma Baay’eeQorannoo 21
- Kansara MetastatikiiQorannoo 20
- Kansarii OvariiQorannoo 19
- ObesityQorannoo 18
- Leukemia Myeloidii HamaaQorannoo 17
- Cufama OnneeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.